Agios Pharmaceuticals Expands Into 21,000 SqFt Facility
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, announced today that it has leased a 21,000 square-foot facility in Cambridge. This new facility creates the world’s largest laboratory dedicated to cancer metabolism research.